REKLAMA

KRKA: Acquisition of treasury shares

2021-01-11 09:14
publikacja
2021-01-11 09:14
Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 1 / 2021
Date of issue: 2021-01-11
Short name of the issuer
KRKA
Subject
Acquisition of treasury shares
Official market - legal basis
Unofficial market - legal basis
Contents of the report:
With a reference to the public notice from 29 July 2020, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 4 January 2021 up to and including 8 January 2021. Krka acquired 8,974 treasury shares in the total value of EUR 835,676 on the Ljubljana Stock Exchange as follows:

- on 4 January 2021: 1,909 shares at a VWAP of EUR 91.09,
- on 5 January 2021: 2,044 shares at a VWAP of EUR 92.45,
- on 6 January 2021: 2,218 shares at a VWAP of EUR 93.29,
- on 7 January 2021: 1,877 shares at a VWAP of EUR 94.47 and
- on 8 January 2021: 926 shares at a VWAP of EUR 95.67.

Price is calculated as volume weighted average price (VWAP).
Ilirika d.d., Intercaptial d.d, and NLB d.d. were brokers in these transactions.

The total number of treasury shares prior to these transactions was 1,541,774 representing 4.701% of all shares issued.
The total number of treasury shares after these transactions is 1,550,748 representing 4.729% of all shares issued.

The notice will be published on the Company's website (www.krka.biz) from 11 January 2021 onwards, for a period of at least 5 years.
Annexes
File Description

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2021-01-11 Jože Colarič President of the Management Board and CEO
Źródło:GPW - komunikaty spółek (ESPI)
Tematy
Kredyt dla firm. Marża od 2,4% z ubezpieczeniem. 0% prowizji za udzielenie.

Kredyt dla firm. Marża od 2,4% z ubezpieczeniem. 0% prowizji za udzielenie.

Advertisement

Komentarze (0)

dodaj komentarz

Powiązane

Polecane

Najnowsze

Popularne

Ważne linki